FDA : Considerations for the Use of Artificial Intelligence to Support Regulatory Decision/Making for Drug and Biological Products (Draft) , Draft Guidance for Industry and Other Interested Parties/ Docket Number:FDA/2024/D/4689 2025.05.14
India 「インド規制当局：中央医薬品基準管理機構（CDSCO）」[Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products Version: 2.0] 2025.04.23
[Press Release 20250211] “Launch of GVP validation consulting service for evaluation of PV System introduction with AI function” 2025.02.12
[Press Release 20241206] “Start of Consulting Support for post/Production GVP Validation Methods for PV Systems with AI functions” 2024.12.06
